| Age stratification, n (%) |
n=80 |
n=1,791 |
|
| Infants (0–1 year old) |
0 (0.0) |
0 (0.0) |
N/A |
| 2–11 years old |
1 (1.3) |
2 (0.1) |
0.013 |
| 12–18 years old |
12 (15.0) |
36 (2.0) |
<0.001 |
| ≥19 years old |
67 (83.8) |
1,753 (97.9) |
<0.001 |
| Age demographics |
n=80 |
n=1,796 |
|
| Average ± SD (years) |
34±13 |
49±13 |
<0.001 |
| Gender, n (%) |
n=79 |
n=1,787 |
|
| Female |
18 (22.8) |
228 (12.8) |
0.010 |
| Pre-implant etiology, n (%) |
n=80 |
n=1,796 |
|
| Ischemic cardiomyopathy (including acute MI and VSD) |
8 (10.0) |
583 (32.5) |
<0.001 |
| Non-ischemic cardiomyopathy |
9 (11.3) |
180 (10.0) |
0.721 |
| Idiopathic dilated cardiomyopathy |
13 (16.3) |
614 (34.2) |
<0.001 |
| Restrictive cardiomyopathy (including amyloidosis, radiation/chemo-induced, sarcoidosis and scleroderma) |
6 (7.5) |
71 (4.0) |
0.118 |
| Viral cardiomyopathy |
0 (0.0) |
41 (2.3) |
0.172 |
| Infectious complications |
1 (1.3) |
16 (0.9) |
0.740 |
| Valvular cardiomyopathy |
5 (6.3) |
88 (4.9) |
0.586 |
| Non-CHD (including familial, arrhythmogenic right ventricular dysplasia, hypertrophic) |
4 (5.0) |
77 (4.3) |
0.759 |
| Post-heart transplant graft failure |
3 (3.8) |
109 (6.1) |
0.392 |
| LVAD failure |
6 (7.5) |
88 (4.9) |
0.297 |
| Post/peri-partum cardiomyopathy |
0 (0.0) |
21 (1.2) |
0.331 |
| Failure to wean |
5 (6.3) |
201 (11.2) |
0.167 |
| Other |
5 (6.3) |
176 (9.8) |
0.293 |
